Grown Rogue Stock GRUSF Stock analysis & Why GRUSF Stock Goes Up

Sarissa’s Alkermes board replacements largely fail to win support from shareholder firms, which cite Biogen board moves

Alex Denner, the investor behind the activist firm Sarissa Capital Management, is not winning much support for his board upheaval plans at Irish drugmaker Alkermes.

June 22, 2023

Intensive blood pressure control reduces dementia risk in adults with hypertension

An intensive, four-year blood-pressure intervention significantly reduced the risk of developing dementia among adults with high blood pressure compared to people who received usual care,

November 13, 2023

How exposure to sugar before age 2 affects diabetes risk

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. After being far from the first person

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.